<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>T. Spelman on Academic</title>
    <link>/authors/t.-spelman/</link>
    <description>Recent content in T. Spelman on Academic</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 01 Jan 2017 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="/authors/t.-spelman/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities</title>
      <link>/publication/rn-1036/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-1036/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection</title>
      <link>/publication/rn-1066/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-1066/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period</title>
      <link>/publication/rn-631/</link>
      <pubDate>Sun, 01 Jan 2012 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-631/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia</title>
      <link>/publication/rn-687/</link>
      <pubDate>Sun, 01 Jan 2012 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-687/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach</title>
      <link>/publication/rn-634/</link>
      <pubDate>Sat, 01 Jan 2011 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-634/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Critical evaluation: Are patients after splenectomy at risk of infections?</title>
      <link>/publication/rn-925/</link>
      <pubDate>Fri, 01 Jan 2010 00:00:00 +0000</pubDate>
      
      <guid>/publication/rn-925/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
